Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Operating Expenses | 2,876 | 2,436 | 3,003 | 3,386 | 3,163 |
| Operating Income | -2,876 | -2,436 | -3,003 | -3,386 | -3,163 |
| Other Income | 154 | 156 | 190 | 173 | 250 |
| Pre-tax Income | -2,722 | -2,280 | -2,813 | -3,213 | -2,913 |
| Net Income Continuous | -2,722 | -2,280 | -2,813 | -3,213 | -2,913 |
| Minority Interests | -27 | -22 | -23 | -29 | -30 |
| Net Income | $-2,695 | $-2,258 | $-2,790 | $-3,184 | $-2,883 |
| EPS Basic Total Ops | -0.08 | -0.07 | -0.09 | -0.10 | -0.09 |
| EPS Basic Continuous Ops | -0.08 | -0.07 | -0.09 | -0.10 | -0.09 |
| EPS Diluted Total Ops | -0.08 | -0.07 | -0.09 | -0.10 | -0.09 |
| EPS Diluted Continuous Ops | -0.08 | -0.07 | -0.09 | -0.10 | -0.09 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.07 | -0.09 | -0.10 | -0.09 |
| EBITDA(a) | $-2,917 | $-2,441 | $-2,821 | $-3,629 | $-3,154 |